Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis
Open accessAbstract
Multiple signalling pathways are involved in the mechanism by which insulin stimulates hepatic glycogen synthesis. In this study we used selective inhibitors of glycogen synthase kinase‐3 (GSK‐3) and an allosteric inhibitor of phosphorylase (CP‐91149) that causes dephosphorylation of phosphorylase a, to determine the relative contributions of inactivation of GSK‐3 and dephosphorylation of phosphorylase a as alternative pathways in the stimulation of glycogen synthesis by insulin in hepatocytes. GSK‐3 inhibitors (SB‐216763 and Li+) caused a greater activation of glycogen synthase than insulin (90% vs. 40%) but a smaller stimulation of glycogen synthesis (30% vs. 150%). The contribution of GSK‐3 inactivation to insulin stimulation of glycogen synthesis was estimated to be less than 20%. Dephosphorylation of phosphorylase a with CP‐91149 caused activation of glycogen synthase and translocation of the protein from a soluble to a particulate fraction and mimicked the stimulation of glycogen synthesis by insulin. The stimulation of glycogen synthesis by phosphorylase inactivation cannot be explained by either inhibition of glycogen degradation or activation of glycogen synthase alone and suggests an additional role for translocation of synthase. Titrations with the phosphorylase inactivator showed that stimulation of glycogen synthesis by insulin can be largely accounted for by inactivation of phosphorylase over a wide range of activities of phosphorylase a. We conclude that a signalling pathway involving dephosphorylation of phosphorylase a leading to both activation and translocation of glycogen synthase is a critical component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Selective inactivation of phosphorylase can mimic insulin stimulation of hepatic glycogen synthesis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insulin inactivates glycogen phosphorylase and glycogen synthase kinase-3 through the PI3K pathway, which in turn activates glycogen synthase.
“Furthermore, insulin inactivates glycogen phosphorylase and glycogen synthase kinase (GSK)-3172 through the PI3K pathway, which in turn activates glycogen synthase.18, 19, 20”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [172]
The introduction (p. 1) describes insulin activating PI3K and, downstream, inactivating GSK-3, which allows glycogen synthase to become activated. The figure model (p. 2) and Discussion (p. 6) also link insulin-induced phosphorylase inactivation to glycogen synthase activation, but they do not establish that phosphorylase is inactivated through the PI3K pathway; the paper treats these as alternative mechanisms. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 37 · Cited by 62
- Authors
- Aiston, S., Coghlan, M. P., & Agius, L.
- Affiliations
- Newcastle University (GB)
- AstraZeneca (United Kingdom) (GB)
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 2003-06-12
- Volume
- 270
- Issue
- 13
- Pages
- 2773-2781
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W1968770488
- Cited by
- 62
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 3 · 2013: 4 · 2012: 1
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Pfizer
- University of Pennsylvania
- Diabetes UK
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- insulin signaling, hepatic glycogen synthesis, glycogen phosphorylase a, glycogen synthase activation, glycogen synthase kinase-3, hepatocytes, glycogenolysis
- MeSH terms
- Amides, Animals, Biological Transport, Cells, Cultured, Enzyme Activation, Enzyme Inhibitors, Glucose, Glycogen, Indoles, Insulin, Male, Phosphorylase a, Signal Transduction, Rats, Wistar, Hepatocytes, Glycogen Synthase Kinase 3, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review